![E. Sutherland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
E. Sutherland
Vorstandsvorsitzender bei
UPSTREAM BIO, INC.
Vermögen: 446 824 $ am 31.07.2026
Profil
E.
Rand Sutherland is Chief Executive Officer & Director at Upstream Bio, Inc. since 2024.
Dr. Sutherland is Independent Director at Krystal Biotech, Inc. since 2022.
Dr. Sutherland is Independent Director at Vanqua Bio, Inc. since 2022.
Formerly, Dr. Sutherland was Chief Executive Officer at Seeker Biologics, Inc. from 2022 to 2023.
Dr. Sutherland was Independent Director at Allakos, Inc. from 2023 to 2024.
Dr. Sutherland was President at Translate Bio, Inc. in 2021.
Dr. Sutherland was Professor at The University of Colorado.
Dr. Sutherland was Chief of Pulmonary at National Jewish Health, Inc. Dr. Sutherland was SVP & Global Head-Medical Affairs at Genzyme Therapeutics Ltd. from 2018 to 2021.
Education includes undergraduate degree from Oberlin College, doctorate from The University of Chicago, and graduate degree from Harvard T.H.
Chan School of Public Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UPSTREAM BIO, INC. 0.13% | 16.06.2026 | 70’812 ( 0.13% ) | 446 824 $ | 31.07.2026 |
| 23.03.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von E. Sutherland
| Unternehmen | Position | Beginn |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Direktor/Vorstandsmitglied | 18.01.2022 |
| UPSTREAM BIO, INC. | Vorstandsvorsitzender | 02.04.2024 |
Vanqua Bio, Inc.
 Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Direktor/Vorstandsmitglied | 01.08.2022 |
Ehemalige bekannte Positionen von E. Sutherland
| Unternehmen | Position | Ende |
|---|---|---|
| ALLAKOS INC. | Direktor/Vorstandsmitglied | 01.05.2024 |
Seeker Biologics, Inc.
 Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs | Vorstandsvorsitzender | 01.06.2023 |
| TRANSLATE BIO, INC. | Präsident | 14.09.2021 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 |
National Jewish Health, Inc.
 National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Corporate Officer/Principal | - |
Ausbildung von E. Sutherland
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Oberlin College
 Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Jewish Health, Inc.
National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Health Services |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Commercial Services |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Seeker Biologics, Inc.
Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs | Health Technology |
